SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Concert Pharmaceuticals, Inc. Presents Findings Demonstrating Enhanced Potency of CTP-221, a Deuterated S-Enantiomer of Lenalidomide